View in EDS HTML Full Text PDF Full Text

Conscientious Enrolment in Clinical Trials during the COVID-19 Pandemic: Right Patient, Right Trial

Saved in:
Bibliographic Details
Title: Conscientious Enrolment in Clinical Trials during the COVID-19 Pandemic: Right Patient, Right Trial
Language: English
Authors: Melanie Arnold (ORCID 0000-0002-7789-3906), Stacie Merritt, Kathryn Mears, Anna Bryan, Jane Bryce
Source: Research Ethics. 2024 20(4):669-682.
Availability: SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail: journals@sagepub.com; Web site: https://sagepub.com
Peer Reviewed: Y
Page Count: 14
Publication Date: 2024
Document Type: Journal Articles
Reports - Descriptive
Descriptors: COVID-19, Pandemics, Experimental Groups, Control Groups, Enrollment, Screening Tests, Ethics, Eligibility, Medical Research
DOI: 10.1177/17470161241241409
ISSN: 1747-0161
2047-6094
Abstract: This article describes our efforts to screen and enrol clinical trial participants conscientiously in the COVID-19 pandemic setting. We present the standard screening and enrolment process prior to, and our process of adapting to, the pandemic. Our goal was to develop a way to screen and enrol people for clinical trials that was both equitable and effective. In addition, we outline the steps our research department took to ensure that ethical, clinical and logistical factors were considered when matching a patient to a clinical trial.
Abstractor: As Provided
Entry Date: 2024
Accession Number: EJ1443258
Database: ERIC
Full text is not displayed to guests.
Description
Abstract:This article describes our efforts to screen and enrol clinical trial participants conscientiously in the COVID-19 pandemic setting. We present the standard screening and enrolment process prior to, and our process of adapting to, the pandemic. Our goal was to develop a way to screen and enrol people for clinical trials that was both equitable and effective. In addition, we outline the steps our research department took to ensure that ethical, clinical and logistical factors were considered when matching a patient to a clinical trial.
ISSN:1747-0161
2047-6094
DOI:10.1177/17470161241241409